Any current/future new fundraising through debt or equity?

No immediate or additional capital raising is planned as the major Capex is mostly complete. The company believes it can manage its current debt and cash flow situation without new fundraising. Upcoming Capex includes the refrigerant gas R32 project, which is not expected to require significant expenditure. Management expects operating cash flows from the CMCD business to become self-sustaining around FY '27-'28, funding future Capex internally. Debt levels are believed to have peaked, with gearing expected to reduce in coming quarters due to improved profitability and green power init

Any current/future capex/capital investment/strategic investment?

Ongoing Capex includes refrigerant gas R32 capacity expansion: - Swing plant conversion of existing R22 plant (~2 kt) to be ready by January 2026. - Another 2 kt plant expected by April 2026. - Plans for a new 10 kt plant under engineering and awaiting regulatory clarity; decision expected by December 2025. - Estimated Capex for the 10 kt plant around INR 250 crores. CMCD (Custom Manufacturing) business expansion: - Targeting to be self-sustaining in operating cash flow by FY '27-'28 with revenues crossing INR 1,000-1,200 crores. - Majority of expansion expected on the existing sit

Future growth expectations in sales/revenue/volumes?

Specialty Chemicals segment is driving growth, with a 10% YoY increase in H1 FY '26, aided by volumes from the new Paste PVC plant at Cuddalore. Custom manufacturing (CMCD) pipeline remains strong with ongoing commercialization of new molecules and active customer engagement. Long-term outlook for CMCD is positive despite near-term price pressure and slower ramp-up of new agrochemical molecules. Value-added Chemicals segment revenue declined 9-12% due to lower caustic production and market softness. Suspension PVC volumes improved 11% YoY despite volatile pricing and competition from Chinese a

Future growth expectations in earnings/operating earnings/profits/EPS?

Chemplast Sanmar anticipates revenue growth in its Custom Manufactured Chemicals (CMC) business, targeting INR1,000-1,200 crores by FY '27-'28. EBITDA margins in CMC are expected to improve to 20%-25% with scale-up. The Paste PVC business is currently facing margin pressures due to low-priced imports, but volumes are increasing; margins are expected to recover as rationalization occurs. New capacities in Paste PVC, CMCD, and refrigerant gas, alongside green energy initiatives, are expected to boost future profitability. Refrigerant gas R-32 capacity expansion is underway, with new plants expec

Current/ Expected Orderbook/ Pending Orders?

The pipeline for the Custom Manufactured Chemicals (CMC) business is mostly agrochemicals, with some projects in non-agrochemicals such as pharma and fine chemicals. The company has commercialized 3 molecules so far this year, with one more expected in Q4 FY '26. Customer engagement remains very strong, and product pipeline traction continues positively. Long-term demand and market projections for the business remain strong despite near-term price pressures. The company's CMC division aims to reach revenues of INR 1,000 crores by FY '27. Overall, the orderbook and project pipeline are robust,

IN US

Sale is live|00:00:00left today

Chemplast Sanmar LtdQ3 FY25Chemicals & Petrochemicals

Chemplast Sanmar Ltd Q3 FY25 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹204Market Cap: ₹3.6K CrSector: Chemicals & Petrochemicals

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

Yes

Order

Yes

Capex

Yes

3 of 5 growth signals are positive.

Full analysis

Revenue guidance

Category 3

→Specialty Chemicals segment is driving growth, with a 10% YoY increase in H1 FY '26, aided by volumes from the new Paste PVC plant at Cuddalore.
→Custom manufacturing (CMCD) pipeline remains strong with ongoing commercialization of new molecules and active customer engagement.
→Long-term outlook for CMCD is positive despite near-term price pressure and slower ramp-up of new agrochemical molecules.
→Value-added Chemicals segment revenue declined 9-12% due to lower caustic production and market softness.
→Suspension PVC volumes improved 11% YoY despite volatile pricing and competition from Chinese and US suppliers.
→Planned capacity expansions in refrigerant gas R32 (starting Q1 2026), and CMCD expect to support future revenue growth.
→Expect CSM segment to achieve INR1,000 crores in revenue by FY 2027-28, maintaining EBITDA margins between 20-25%.
→Indian PVC demand remains strong and growing; capacity expansions are unlikely to make India a net exporter in near term.

Margin guidance

Category 3

→Chemplast Sanmar anticipates revenue growth in its Custom Manufactured Chemicals (CMC) business, targeting INR1,000-1,200 crores by FY '27-'28.
→EBITDA margins in CMC are expected to improve to 20%-25% with scale-up.
→The Paste PVC business is currently facing margin pressures due to low-priced imports, but volumes are increasing; margins are expected to recover as rationalization occurs.
→New capacities in Paste PVC, CMCD, and refrigerant gas, alongside green energy initiatives, are expected to boost future profitability.
→Refrigerant gas R-32 capacity expansion is underway, with new plants expected to be operational by early-mid 2026, supporting growth.
→Debt levels have peaked; improved cash flows from higher capacities and green power are expected to reduce leverage going forward.
→Overall, a sequential recovery in operating performance was noted, with optimism for stronger future earnings as capacity ramp-up and market conditions improve.

3 more insights locked — sign up free to unlock

Fundraise plans

Yes

→No immediate or additional capital raising is planned as the major Capex is mostly complete.
→The company believes it can manage its current debt and cash flow situation without new fundraising.
→Upcoming Capex includes the refrigerant gas R32 project, which is not expected to require significant expenditure.
→Management expects operating cash flows from the CMCD business to become self-sustaining around FY '27-'28, funding future Capex internally.
→Debt levels are believed to have peaked, with gearing expected to reduce in coming quarters due to improved profitability and green power initiatives.
→There is confidence in managing existing leverage without external capital infusion at present.

Order book

Yes

→The pipeline for the Custom Manufactured Chemicals (CMC) business is mostly agrochemicals, with some projects in non-agrochemicals such as pharma and fine chemicals.
→The company has commercialized 3 molecules so far this year, with one more expected in Q4 FY '26.
→Customer engagement remains very strong, and product pipeline traction continues positively.
→Long-term demand and market projections for the business remain strong despite near-term price pressures.
→The company's CMC division aims to reach revenues of INR 1,000 crores by FY '27.
→Overall, the orderbook and project pipeline are robust, supporting the company's growth and capacity ramp-up plans.

Capex plans

Yes

→Ongoing Capex includes refrigerant gas R32 capacity expansion:
→ - Swing plant conversion of existing R22 plant (~2 kt) to be ready by January 2026.
→ - Another 2 kt plant expected by April 2026.
→ - Plans for a new 10 kt plant under engineering and awaiting regulatory clarity; decision expected by December 2025.
→ - Estimated Capex for the 10 kt plant around INR 250 crores.
→CMCD (Custom Manufacturing) business expansion:
→ - Targeting to be self-sustaining in operating cash flow by FY '27-'28 with revenues crossing INR 1,000-1,200 crores.
→ - Majority of expansion expected on the existing site at Berigai, with a backup alternate site identified.
→Major Paste PVC and Suspension PVC plants commissioned recently; capacity ramp-up ongoing.
→Green power initiatives underway to improve profitability and support future growth.
→Debt levels have peaked; deleveraging expected as benefits of new capacities and green power materialize.

How does Chemplast Sanmar Ltd rank vs peers in Chemicals & Petrochemicals?

Pro feature

1Chemplast Sanmar Ltd

Rev 3Mar 3

See full Chemicals & Petrochemicals sector rankings

Want more stocks like Chemplast Sanmar Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio